advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

Healthcare Market Research

Get the necessary research you need for the Healthcare Industry. Our catalogue of reports provides information on health maintenance organisations (HMO), Hospitals and Healthcare Insurance.

Stay up-to-date with new products added to this category
Title Date Price
Aeolus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Inhibitex, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Incyte Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Introgen Therapeutics, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Halozyme Therapeutics - Financial and Strategic Analysis Review
Apr 2009 £77
Inspire Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Biotron Limited - Financial and Strategic Analysis Review
Apr 2009 £77
Acusphere, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Acura Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Access Pharmaceuticals - Financial and Strategic Analysis Review
Apr 2009 £77
CEL-SCI Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Alfacell Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Bioniche Life Sciences - Financial and Strategic Analysis Review
Apr 2009 £77
Chugai Pharmaceutical Co. Ltd - Financial and Strategic Analysis Review
Apr 2009 £77
Advanced Cell Technology, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Arpida Ltd. - Financial and Strategic Analysis Review
Apr 2009 £77
Inyx, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Martek Biosciences Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
STADA Arzneimittel AG - Financial and Strategic Analysis Review
Apr 2009 £77
AutoImmune Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Exelixis, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Indevus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Ramsay Health Care Limited - Financial and Strategic Analysis Review
Apr 2009 £77
Favrille, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
GW Pharmaceuticals plc - Financial and Strategic Analysis Review
Apr 2009 £77
Hana Biosciences, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
GeoPharma, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
GENTIUM S.p.A. - Financial and Strategic Analysis Review
Apr 2009 £77
Genetic Technologies Limited - Financial and Strategic Analysis Review
Apr 2009 £77
HEALTHWAYS, INC - Financial and Strategic Analysis Review
Apr 2009 £77
Advanced Proteome Therapeutics Corp. - Financial and Strategic Analysis Review
Apr 2009 £77
Agenix ltd. - Financial and Strategic Analysis Review
Apr 2009 £77
Hemispherx Biopharma, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Helix BioMedix, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Akorn, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Alizyme plc - Financial and Strategic Analysis Review
Apr 2009 £77
Akesis Pharmaceuticals Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Alchemia Limited - Financial and Strategic Analysis Review
Apr 2009 £77
Advanced Viral Research Corp. - Financial and Strategic Analysis Review
Apr 2009 £77
3SBio Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Generex Biotechnology Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Addex Pharmaceuticals - Financial and Strategic Analysis Review
Apr 2009 £77
EntreMed, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
GammaCan International Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Exact Sciences Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Eurand N.V. - Financial and Strategic Analysis Review
Apr 2009 £77
etrials Worldwide, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Wyeth - Financial and Strategic Analysis Review
Apr 2009 £77
Agilent Technologies Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Shire Plc - Financial and Strategic Analysis Review
Apr 2009 £77
Schering-Plough Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Quest Diagnostics Incorporated - Financial and Strategic Analysis Review
Apr 2009 £77
Onyx Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Celgene Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Kendle International Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
E.I. du Pont de Nemours and Company - Financial and Strategic Analysis Review
Apr 2009 £77
Alexion Pharmaceuticals - Financial and Strategic Analysis Review
Apr 2009 £77
ADVENTRX Pharmaceuticals - Financial and Strategic Analysis Review
Apr 2009 £77
Groupe Steria SCA - Financial and Strategic Analysis Review
Apr 2009 £77
Health Net, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Chattem, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Crucell N.V. - Financial and Strategic Analysis Review
Apr 2009 £77
ZymoGenetics, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Winn-Dixie Stores, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Warner Chilcott Limited - Financial and Strategic Analysis Review
Apr 2009 £77
VIVUS, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Cell Therapeutics, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Genmab AS - Financial and Strategic Analysis Review
Apr 2009 £77
CV Therapeutics, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Solvay SA - Financial and Strategic Analysis Review
Apr 2009 £77
Enzon Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Progenics Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Allos Therapeutics, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Alnylam Pharmaceuticals, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Dyax Corp. - Financial and Strategic Analysis Review
Apr 2009 £77
Wipro Limited - Financial and Strategic Analysis Review
Apr 2009 £77
Apria Healthcare Group Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Denki Kagaku Kogyo Kabushiki Kaisha - Financial and Strategic Analysis Review
Apr 2009 £77
Forest Laboratories, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Biodel Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Mentor Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
Nanogen, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
InSite Vision Incorporated - Financial and Strategic Analysis Review
Apr 2009 £77
Mediware Information Systems, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
Bayer Schering Pharma AG - Financial and Strategic Analysis Review
Apr 2009 £77
DUSA Pharmaceuticals, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Biovail Corp - Financial and Strategic Analysis Review
Apr 2009 £77
Bionovo, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
BioCryst Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Apr 2009 £77
ARYx Therapeutics - Financial and Strategic Analysis Review
Apr 2009 £77
Flamel Technologies S.A. - Financial and Strategic Analysis Review
Apr 2009 £77
CombinatoRx, Incorporated - Financial and Strategic Analysis Review
Apr 2009 £77
Cytokinetics, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
Cypress Bioscience, Inc - Financial and Strategic Analysis Review
Apr 2009 £77
CSL Ltd - Financial and Strategic Analysis Review
Apr 2009 £77
Genaera Corporation - Financial and Strategic Analysis Review
Apr 2009 £77
H Lundbeck AS - Financial and Strategic Analysis Review
Apr 2009 £77

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Innovations in Oncology Drug Discovery, Development & Delivery

01 Dec 09 to 01 Dec 09
N/A, UK
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Pharma & Healthcare

Customer Services

How To Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis